Literature DB >> 1281185

Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes.

B D Freedman1, M A Price, C J Deutsch.   

Abstract

The membrane potential of human PBMC was modulated in culture by isotonic high extracellular K+ (K+e), or the K+ channel blocker, charybdotoxin (ChTX), to determine the effect of depolarization on stimulated proliferation, IL-2 elaboration, and gene expression. In serum-free cultures, ChTX and high [K+]e induced a specific dose-dependent decrease in IL-2 production. ChTX inhibited proliferation of PBMC and purified T cells, decreased IL-2 elaboration 15 h after stimulation by 78.4 +/- 5.3% (n = 5), and decreased IL-2 mRNA steady-state levels by 80% between 8 and 10 h after stimulation. The IC50 for ChTX-inhibition of IL-2 elaboration and IL-2 mRNA were both 1 nM. Similarly, high [K+]e inhibited proliferation with an IC50 of 38.9 +/- 1.1 mM (n = 13), decreased IL-2 elaboration with an IC50 of 21.3 +/- 1.2 mM (n = 6), and decreased IL-2 mRNA steady-state levels with an IC50 of 18 mM. The sensitivities of both IL-2 production and proliferation to depolarization were substantially reduced by calcium, serum, and exogenous rIL-2. From these findings we conclude that membrane potential may contribute to the control of immune responsiveness in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Authors:  D C Hanson; A Nguyen; R J Mather; H Rauer; K Koch; L E Burgess; J P Rizzi; C B Donovan; M J Bruns; P C Canniff; A C Cunningham; K A Verdries; E Mena; J C Kath; G A Gutman; M D Cahalan; S Grissmer; K G Chandy
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity.

Authors:  Jianchao Xu; Peili Wang; Yanyan Li; Guoyong Li; Leonard K Kaczmarek; Yanling Wu; Pandelakis A Koni; Richard A Flavell; Gary V Desir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

Review 3.  Stress-induced corneal epithelial apoptosis mediated by K+ channel activation.

Authors:  Luo Lu
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

Review 4.  Role of membrane potential in the regulation of cell proliferation and differentiation.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Stem Cell Rev Rep       Date:  2009-06-27       Impact factor: 5.739

5.  A voltage-dependent role for K+ in recovery from C-type inactivation.

Authors:  D I Levy; C Deutsch
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

6.  Recovery from C-type inactivation is modulated by extracellular potassium.

Authors:  D I Levy; C Deutsch
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

7.  A charybdotoxin-insensitive conductance in human T lymphocytes: T cell membrane potential is set by distinct K+ channels.

Authors:  J A Verheugen; H Korn
Journal:  J Physiol       Date:  1997-09-01       Impact factor: 5.182

8.  Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.

Authors:  L E Pereira; F Villinger; H Wulff; A Sankaranarayanan; G Raman; A A Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2007-11

9.  Modulation of rabbit corneal epithelial cell proliferation by growth factor-regulated K(+) channel activity.

Authors:  C Roderick; P S Reinach; L Wang; L Lu
Journal:  J Membr Biol       Date:  2003-11-01       Impact factor: 1.843

10.  Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences.

Authors:  Núria Villalonga; Miren David; Joanna Bielanska; Rubén Vicente; Núria Comes; Carmen Valenzuela; Antonio Felipe
Journal:  J Gen Physiol       Date:  2010-02       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.